Richard L. Edelson
32Patents
14h-index
15Co-inventors
78Inventor score
Filing activity: Dec 11, 1979 → Nov 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4321919A | Method and system for externally treating human blood | Emerging Cross-Sectional Technologies | 102 | Expired |
| US4613322A | Method and system for externally treating the blood | Emerging Cross-Sectional Technologies | 98 | Expired |
| US4428744A | Method and system for externally treating the blood | Emerging Cross-Sectional Technologies | 75 | Expired |
| US4683889A | Method and system for externally treating the blood | Human Necessities | 73 | Expired |
| US4398906A | Method for externally treating the blood | Emerging Cross-Sectional Technologies | 71 | Expired |
| US4464166A | Method for externally treating the blood | Emerging Cross-Sectional Technologies | 69 | Expired |
| US4684521A | Method and system for externally treating the blood | Human Necessities | 65 | Expired |
| US4612007A | Method and system for externally treating the blood | Emerging Cross-Sectional Technologies | 64 | Expired |
| US5114721A | Preparation of T-cell and T-cell membrane for use in prevention and treatment of autoimmune diseases | Human Necessities | 62 | Expired |
| US4838852A | Active specific immune suppression | Human Necessities | 57 | Expired |
| US5147289A | Non-specific immune system enhancement | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5383847A | Non-specific immune system enhancement | Human Necessities | 23 | Expired |
| US5820872A | Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor | Human Necessities | 19 | Expired |
| US5651993A | Specific immune system modulation | Human Necessities | 16 | Expired |
| US5462733A | Immune system modulation using psoralens activated with visible light | Human Necessities | 14 | Expired |
| US6524855B2 | Methods for inducing the differentiation of monocytes into functional dendritic cells | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5256648A | Selective inhibition of gene expression by photoactivatable oligonucleotides | Chemistry; Metallurgy | 11 | Expired |
| US6607722B2 | Methods for inducing the differentiation of monocytes into functional dendritic cells | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7109031B2 | Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells | Chemistry; Metallurgy | 5 | Expired |
| US4868311A | Biotinylated psoralens | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8524495B2 | Methods for inducing the differentiation of blood monocytes into functional dendritic cells | Chemistry; Metallurgy | 4 | Active |
| US7727523B2 | Method for suppressing immune system response to transplanted tissue or cells | Chemistry; Metallurgy | 2 | Expired |
| US7625557B2 | Method for inducing selectively suppressed immune response to transplanted tissue or cells | Human Necessities | 2 | Expired |
| US9321991B2 | Methods for inducing the differentiation of blood monocytes into functional dendritic cells | Chemistry; Metallurgy | 2 | Active |
| US10087418B2 | Methods for inducing the differentiation of blood monocytes into functional dendritic cells | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.